Project Grant 15PBJA21GG04571COAP

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a randomized clinical trial to evaluate the effectiveness of targeted cognitive skills training interventions for offenders with substance use disorders. The $3,226,170 award, spanning September 2024 through May 2029, will be used by the Lovelace Biomedical Research Institute to conduct the trial. The research aims to validate prior findings...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,164,152 to the University of Illinois to test the effectiveness and implementation of a meditation mobile application addressing substance use, sexual health, and emotion regulation among youth involved in the legal system. The key objectives of this 5-year award are to: 1) Conduct a hybrid effectiveness-implementation randomized...

This Project Grant award of $404,616 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to evaluate the feasibility, acceptability, and preliminary efficacy of the "CHAMPION" intervention. The CHAMPION intervention combines two mobile health technologies - a PrEP app and virtual cognitive behavioral therapy - to increase PrEP adherence among 100 HIV-negative methamphetamine-using men who have sex with men (MSM). The...

This Project Grant award of $857,121 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and test a prototype mobile health application (mHealth app) called R-Assist. The app is designed to support individuals with co-occurring opioid use and mental health disorders upon release from jail, providing daily symptom and medication monitoring, a self-help curriculum, social determinants of health resource finder, and an...

The National Institute on Drug Abuse (NIDA) awarded a $959,964 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Charles River Analytics, Inc. to design and demonstrate the feasibility of a prototype system called Stimulant Use Recovery via Immersive Virtual Environments (SURVIVE). The goal of SURVIVE is to provide controlled environmental stimulant use disorder (STUD) triggers and cognitive behavioral therapy (CBT) embedded into virtual environments to reduce...

This federal Project Grant award of $844,475, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to test a bundled intervention to increase treatment uptake for patients with opioid use disorder (OUD) after emergency department (ED) discharge. The project will enroll 30 patients with OUD and nonfatal opioid overdoses in the R61 phase to assess the feasibility and acceptability of the bundled intervention, which...

The Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS), as the lead agency, received a $1,082,468 Project Grant award from the Bureau of Justice Assistance for the FY23 Improving Substance Abuse Disorder Treatment and Recovery Outcomes for Adults in Reentry program. The 4-year "Recovery Matters" project will target individuals exiting incarceration with substance use disorders, particularly those in need of medication-assisted treatment services, who are...

This federal Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) provides $321,842 to Arizona State University to develop and test innovative technologies integrating physiological monitoring and adaptive, personalized mindfulness-based interventions (MBIs) to aid in the sustainable recovery of opioid use disorder (OUD). The key products and services to be delivered under this award include: Identifying...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative and highly scalable digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders (OUD-AUD). The $390,000 award aims to: 1) identify optimal settings and approaches to engage this population in digital CM through Medicaid claims data analysis;...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,264,863 to Rutgers, The State University of New Jersey to conduct research on combining the use of the drug guanfacine and mindfulness meditation as an adjunct to buprenorphine maintenance therapy for individuals with opioid use disorder (OUD). The research aims to evaluate the efficacy and neural mechanisms of using guanfacine, an...